Goldman Sachs’s Rhythm Pharmaceuticals RYTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$110M Buy
1,733,722
+95,814
+6% +$6.05M 0.01% 721
2025
Q1
$86.8M Sell
1,637,908
-174,298
-10% -$9.23M 0.01% 743
2024
Q4
$101M Sell
1,812,206
-2,067,590
-53% -$116M 0.02% 674
2024
Q3
$203M Sell
3,879,796
-1,408,839
-27% -$73.8M 0.03% 444
2024
Q2
$217M Buy
5,288,635
+177,034
+3% +$7.27M 0.04% 422
2024
Q1
$221M Buy
5,111,601
+63,667
+1% +$2.76M 0.04% 401
2023
Q4
$232M Sell
5,047,934
-112,607
-2% -$5.18M 0.04% 379
2023
Q3
$118M Sell
5,160,541
-25,472
-0.5% -$584K 0.03% 548
2023
Q2
$85.5M Sell
5,186,013
-124,690
-2% -$2.06M 0.02% 677
2023
Q1
$94.7M Buy
5,310,703
+108,911
+2% +$1.94M 0.02% 626
2022
Q4
$151M Buy
5,201,792
+424,614
+9% +$12.4M 0.04% 452
2022
Q3
$117M Buy
4,777,178
+1,616,792
+51% +$39.6M 0.03% 533
2022
Q2
$13.1M Sell
3,160,386
-179,364
-5% -$744K ﹤0.01% 1915
2022
Q1
$38.5M Buy
3,339,750
+243,202
+8% +$2.8M 0.01% 1274
2021
Q4
$30.9M Buy
3,096,548
+191,229
+7% +$1.91M 0.01% 1451
2021
Q3
$37.9M Buy
2,905,319
+1,837,108
+172% +$24M 0.01% 1280
2021
Q2
$20.9M Buy
1,068,211
+409,057
+62% +$8.01M ﹤0.01% 1711
2021
Q1
$14M Buy
659,154
+606,742
+1,158% +$12.9M ﹤0.01% 1948
2020
Q4
$1.56M Sell
52,412
-3,856
-7% -$115K ﹤0.01% 3209
2020
Q3
$1.22M Buy
56,268
+23,195
+70% +$503K ﹤0.01% 3199
2020
Q2
$738K Sell
33,073
-18,841
-36% -$420K ﹤0.01% 3400
2020
Q1
$790K Sell
51,914
-12,927
-20% -$197K ﹤0.01% 3242
2019
Q4
$1.49M Buy
64,841
+12,949
+25% +$297K ﹤0.01% 3113
2019
Q3
$1.12M Sell
51,892
-3,952
-7% -$85.3K ﹤0.01% 3185
2019
Q2
$1.23M Buy
55,844
+8,878
+19% +$195K ﹤0.01% 3071
2019
Q1
$1.29M Buy
46,966
+26,935
+134% +$738K ﹤0.01% 3146
2018
Q4
$538K Buy
20,031
+9,561
+91% +$257K ﹤0.01% 3387
2018
Q3
$305K Buy
10,470
+2,952
+39% +$86K ﹤0.01% 3661
2018
Q2
$235K Buy
+7,518
New +$235K ﹤0.01% 3828